For Verified U.S. Accredited Investors Allocating $100,000 or More
Cebron Financial Group's 12-month private promissory note pays $3,000 in cash every 90 days on a $100,000 allocation, with zero management fees and principal due at Month 12 under definitive note agreements. No decade-long lockup. No capital calls.
Offered under Rule 506(c) exclusively to verified U.S. accredited investors. All private investments carry risk, including the potential loss of principal.
HOW IT WORKS
Complete a two-minute form to confirm your accredited investor eligibility for this Rule 506(c) offering.
WHAT YOU PROVIDE
Know if you qualify within 24 to 48 hours. No obligation to invest.
Discuss the note terms and quarterly distributions with our private opportunities team.
WHAT YOU PROVIDE
Review the private placement memorandum and agreements before deciding.
Sign the note agreements and fund at least $100,000. Your first quarterly cash distribution is scheduled for Day 90.
WHAT YOU PROVIDE
Four scheduled $3,000 payments per $100,000, with principal due at Month 12.
THE NOTE, WITH INTENTION
The rate is set in the note agreement, not by the market. You know exactly what your capital is contracted to earn before you allocate a single dollar.
Interest is paid quarterly in cash, $3,000 per quarter on every $100,000. Your first scheduled distribution arrives at Day 90, not years into a fund's J-curve.
Principal is due at Month 12 under definitive note agreements. That's a clear end date, not the seven-to-ten-year lockup typical of private equity funds.
There's no 2% annual fee and no sponsor overhead charged to noteholders. 100% of your allocation goes directly into the note.
Your return is set by contract, not by a future company sale, public market multiples, or daily price swings. You hold a debt instrument, not a speculative ownership stake.
Your interest payments and principal sit senior to Cebron's equity holders under the note agreement. Lenders are positioned ahead of owners.
You fund once and hold a direct promissory obligation of Cebron Financial Group, Inc. Notes are issued in capped tranches tied to specific near-term activity, not an open-ended fund.
Every qualified investor speaks with Cebron's executive team, not a call center. You get answers from the people who allocate the capital.
THE PEOPLE. THE PLATFORMS. THE ISSUER.
Cebron Financial Group, Inc. is an Irvine, California holding company focused on building acquisition platforms for the long term.
We are building acquisition platforms in essential sectors:
These are industries the economy can't run without.
Michael Megarit, Chairman and CEO, leads Cebron's capital allocation, leader selection, and governance. JR Hart, Vice President of M&A, leads the acquisition side. As principals, they're invested in what they build.
Company background and platform development information, not investor testimonials. Company website: Cebron Financial Group
INVESTOR BACKING & PLATFORM CREDIBILITY
The medical device platform Cebron is developing has raised capital from high-net-worth individuals and is pursuing acquisitions with experienced executives.
About $1.8M
The medical device platform Cebron is working on has raised about $1.8 million from high-net-worth individuals.
Capital raised by the platform, not Cebron Financial Group. The platform is in development.
$20M-$50M
With a team of experienced executives, the medical device platform is pursuing acquisition targets with revenues from $20 million to $50 million.
Acquisition targets in pursuit, not completed acquisitions or Cebron revenue.
Acquisition and consolidation is the strategy behind companies such as United Rentals, XPO and Constellation Software.
These companies are strategy examples only. No affiliation, endorsement or relationship with Cebron Financial Group is implied.
Platform development and acquisition strategy, not historical note performance.
FREQUENTLY ASKED QUESTIONS